Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Charles Van Liew, Gabriel Leon, Mikayla Neese & Terry A. Cronan. (2019) You get used to it, or do you: symptom length predicts less fibromyalgia physical impairment, but only for those with above-average self-efficacy. Psychology, Health & Medicine 24:2, pages 207-220.
Read now
Read now
Charles Van Liew, Kimberly C. Brown, Terry A. Cronan & Silvia M. Bigatti. (2013) The Effects of Self-Efficacy on Depression and Pain in Fibromyalgia Syndrome: Does Initial Depression Matter?. Journal of Musculoskeletal Pain 21:2, pages 113-125.
Read now
Read now
Amy Wachholtz, Gerardo Gonzalez, Edward Boyer, Zafar N Naqvi, Christopher Rosenbaum & Douglas Ziedonis. (2011) Intersection of chronic pain treatment and opioid analgesic misuse: causes, treatments, and policy strategies. Substance Abuse and Rehabilitation 2, pages 145-162.
Read now
Read now
Articles from other publishers (15)
Man Soo Kim, In Jun Koh, Keun Young Choi, Sung Cheol Yang & Yong In. (2021) Efficacy of duloxetine compared with opioid for postoperative pain control following total knee arthroplasty. PLOS ONE 16:7, pages e0253641.
Crossref
Crossref
Sevgi Gümüş Atalay. (2018) The Association of IGF-1 with Clinical Symptoms in Female Patients With Fibromyalgia Syndrome. Ankara Medical Journal.
Crossref
Crossref
Antonio Bedin, Rafael A. Caldart Bedin, Joaquim E. Vieira & Hazem A. Ashmawi. (2017) Duloxetine as an Analgesic Reduces Opioid Consumption After Spine Surgery. The Clinical Journal of Pain 33:10, pages 865-869.
Crossref
Crossref
Christine Won & Douglas Kirsch. 2017. Principles and Practice of Sleep Medicine. Principles and Practice of Sleep Medicine
1294
1299.e4
.
Malene Cording, Sheena Derry, Tudor Phillips, R Andrew Moore & Philip J Wiffen. (2015) Milnacipran for pain in fibromyalgia in adults. Cochrane Database of Systematic Reviews 2019:5.
Crossref
Crossref
Izaque S. Maciel, Rodrigo B. M. Silva, Fernanda B. Morrone, João B. Calixto & Maria M. Campos. (2013) Synergistic Effects of Celecoxib and Bupropion in a Model of Chronic Inflammation-Related Depression in Mice. PLoS ONE 8:9, pages e77227.
Crossref
Crossref
Suwimon Yeephu, Chuthamanee Suthisisang, Saithip Suttiruksa, Pradit Prateepavanich, Patchara Limampai & Irwin Jon Russell. (2013) Efficacy and Safety of Mirtazapine in Fibromyalgia Syndrome Patients: A Randomized Placebo-Controlled Pilot Study. Annals of Pharmacotherapy 47:7-8, pages 921-932.
Crossref
Crossref
Joseph F. Audette. 2013. Pain in Women. Pain in Women
59
93
.
Héctor Arreola Ornelas, Alfonso Rosado Buzzo, Lourdes García, Javier Dorantes Aguilar, Iris Contreras Hernández & Joaquín F. Mould Quevedo. (2012) Cost-effectiveness Analysis of Pharmacologic Treatment of Fibromyalgia in Mexico. Reumatología Clínica (English Edition) 8:3, pages 120-127.
Crossref
Crossref
Pierre A. Geoffroy, Ali Amad, Christine Gangloff & Pierre Thomas. (2012) Fibromyalgie et psychiatrie : 35 ans plus tard… Quoi de neuf ?. La Presse Médicale 41:5, pages 455-465.
Crossref
Crossref
Sheena Derry, Dipender Gill, Tudor Phillips & R Andrew Moore. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Héctor Arreola Ornelas, Alfonso Rosado Buzzo, Lourdes García, Javier Dorantes Aguilar, Iris Contreras Hernández & Joaquín F. Mould Quevedo. (2012) Análisis de coste-efectividad en el tratamiento farmacológico del síndrome de fibromialgia en México. Reumatología Clínica.
Crossref
Crossref
Kristin K. Barker. (2011) Listening to Lyrica: contested illnesses and pharmaceutical determinism. Social Science & Medicine 73:6, pages 833-842.
Crossref
Crossref
Jean-Pascal Lefaucheur. (2011) Is rTMS a therapeutic option in chronic pain syndrome? Insights from the treatment of fibromyalgia. Pain 152:7, pages 1447-1448.
Crossref
Crossref
Jamie N. BrownDustin T. Wilson. (2011) Safety and Efficacy of Armodafinil in the Treatment of Excessive Sleepiness. Clinical Medicine Insights: Therapeutics 3, pages CMT.S5124.
Crossref
Crossref